Feb 26, 2026 10:36AM
Jan 6, 2026 03:13PM
Nov 5, 2025 07:01AM
Oct 21, 2025 11:24PM
Oct 21, 2025 11:24PM
Oct 21, 2025 04:01PM
Oct 21, 2025 04:01PM Viridian Therapeutics Announces Proposed Underwritten Public Offering
Aug 25, 2025 07:47AM
May 30, 2025 07:00AM
Sep 12, 2024 06:12AM
Sep 11, 2024 11:25PM
Sep 10, 2024 04:01PM
Sep 10, 2024 04:01PM
May 31, 2024 08:00AM Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences
Jan 18, 2024 05:07AM
Jan 17, 2024 10:00PM
Jan 17, 2024 04:01PM
Jan 17, 2024 04:01PM
Nov 8, 2023 08:00AM
Oct 30, 2023 08:31AM
Oct 30, 2023 08:30AM Viridian Therapeutics Appoints New Chief Executive Officer, Unveils Next Generation FcRn Inhibitor Programs and Announces $185 Million Private Placement Financing
Aug 25, 2022 04:03PM
Aug 17, 2022 06:02AM
Aug 17, 2022 06:00AM
Aug 15, 2022 04:01PM
Aug 15, 2022 04:01PM
Jun 1, 2022 08:00AM
Nov 3, 2021 04:05PM Viridian Therapeutics to Present at Upcoming Investor Conferences
Sep 23, 2021 04:01PM
Sep 21, 2021 05:50AM
Sep 21, 2021 12:22AM
Sep 20, 2021 04:01PM
Sep 20, 2021 04:01PM
May 14, 2021 08:00AM
Jan 20, 2021 08:06AM Jefferies Assumes Viridian Therapeutic (VRDN) at Buy

69,742 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All